Can the neutrophil-lymphocyte ratio predict type 1 hereditary angioedema attacks?

Area of Science:

• Immunology
• Hematology
• Genetics

Background:

• Inflammation assessment is crucial in managing chronic conditions.
• The neutrophil-lymphocyte ratio (NLR) is a recognized, accessible biomarker for systemic inflammation.
• Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent, unpredictable swelling episodes.

Purpose of the Study:

• To investigate the predictive value of the neutrophil-lymphocyte ratio (NLR) for episode occurrence in patients with hereditary angioedema (HAE).
• To assess the correlation between NLR and HAE episode frequency.

Main Methods:

• A study involving 66 patients with Type 1 HAE and 60 healthy controls.
• Comparison of NLR values during HAE episodes versus episode-free periods.
• Analysis of laboratory results, including NLR, in relation to HAE activity.

Main Results:

• NLR values were significantly higher in HAE patients during active episodes compared to their own episode-free periods (median 3.5 vs. 2.0, p < .001).
• Laboratory results during episode-free periods were comparable to those of healthy controls.
• A significant positive correlation (r = 0.557, p < .001) was observed between the number of HAE episodes and the NLR calculated during episodes.

Conclusions:

• The neutrophil-lymphocyte ratio (NLR) demonstrates significant predictive potential for episode frequency in hereditary angioedema.
• NLR is a cost-effective and easily calculable parameter that clinicians can utilize to anticipate HAE attack burden.
• This finding supports the integration of NLR monitoring into HAE management strategies for improved patient care.